SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sirna Therapeutics Inc
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
562 31 0 RNAI
Emcee:  advinfo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
437Phase II Hepatitis C Trial Initiated by Ribozyme Pharmaceuticals biz.yahoo.comSemiBull-10/8/2001
436>>BOULDER, Colo., Sept. 25 /PRNewswire/ -- Ribozyme Pharmaceuticals Inc. (tuck-9/25/2001
435"What are your other picks in the biotech basket?" CORR, CEGE, CRIS, SemiBull-8/30/2001
434Thanks, Semi. As for tea leaves, I was referring to the later stage trials, thoThomas-8/30/2001
433It is a Phase I, so any tea leaf reading would not be worth a bunch. I am bulliSemiBull-8/30/2001
432Hi Semi, Thanks for the news. Any thoughts? Any tea leaf reading (what we are Thomas-8/30/2001
431RPI Initiates HERZYME(TM) Phase I Clinical Trial in Breast and Ovarian Cancer biSemiBull-8/29/2001
430Ribozyme Pharmaceuticals, Inc. Reports Second Quarter Financial Results biz.yahoSemiBull-8/14/2001
429RZYM filed S-3 shelf registration on Friday for the issuance of up to $10mm of sThomas-7/30/2001
428Rumors swirling around potential CHIR acquisition of RZYM, from "in betweenThomas-7/8/2001
427Ribozyme and Chiron Commence Phase II ANGIOZYME(TM) Colorectal Cancer Trial biz.SemiBull-6/20/2001
426Ribozyme Pharmaceuticals Appoints Marvin Tancer As CFO and V.P. of Operations biSemiBull-6/11/2001
425Ribozyme Pharmaceuticals, Inc. Reports First Quarter Financial Results biz.yahooSemiBull-5/14/2001
424Ribozyme Pharmaceuticals and Archemix Enter Into a Proteomics and Molecular DiagSemiBull-5/9/2001
423RZYM CEO: Breakthrough Drug Technology Undervalued by Street biz.yahoo.comSemiBull-4/3/2001
422Ribozyme Pharmaceuticals, Inc. Reports Fourth Quarter And Year End Financial ResSemiBull-3/29/2001
421Wolfdog2: I'm with you on not renewing CTSL. MM's calls on economic cotigeral-3/24/2001
420OT. tigeral, interesting you mention MM and MTSL. I just decided not to renew mwolfdog2-3/24/2001
419Hi WolfDog2 and SemiBull. Some of your recent posts caught my eye. I own Rzym thtigeral-3/24/2001
418I think you have use newsletters for, or in support of fundamental and not technSemiBull-3/5/2001
417I used to subscribe to MTSL and recently took a trial subscription. Based on MTwolfdog2-3/4/2001
416Understand....different baskets for different approaches. I am familiar with SESemiBull-3/4/2001
415SemiBull, I also use basket approach, but I prefer to fill my basket with stockswolfdog2-3/3/2001
414Wolfdog2, I prefer the basket theory to biotech investing focusing mostly on eaSemiBull-3/3/2001
413SemiBull, I own the stock. One of my mistakes! I actually like the company buwolfdog2-3/2/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News